CAS 71539-52-1

Oxycodone N-Oxide

Controlled Product

CAS: 71539-52-1

Formula: C₁₈H₂₁NO₅

Color and Shape: Neat

Molecular weight: 331.36

Ref: 86-MM0672.06

Oxycodone N-Oxide (1.0mg/ml in Methanol)

Controlled Product

CAS: 71539-52-1

Formula: C₁₈H₂₁NO₅

Color and Shape: Colourless

Molecular weight: 331.36

Ref: TR-KIT2385

Oxycodone N-Oxide

Controlled Product

CAS: 71539-52-1

Applications Oxycodone N-Oxide is a metabolite of Oxycodone (O870600), a semisynthetic codeine derivative that has been used both as an analgesic and antitussive.
References Moore, K.A. et al.: J. Anal. Toxicol., 27, 346 (2003); Ishida, T. et al.: J. Pharmacobio-Dyn., 5, 521 (1982); Ishida, T. et al.: Drug Metab. Dispos., 7, 162 (1979);

Formula: C₁₈H₂₁NO₅

Color and Shape: White To Light Yellow

Molecular weight: 331.36

Ref: TR-O870610

Oxycodone-d3 N-Oxide

Controlled Product

CAS: 71539-52-1

Applications Labelled analogue of Oxycodone N-Oxide, a metabolite of Oxycodone (O870600), a semisynthetic codeine derivative that has been used both as an analgesic and antitussive.
References Moore, K.A. et al.: J. Anal. Toxicol., 27, 346 (2003); Ishida, T. et al.: J. Pharmacobio-Dyn., 5, 521 (1982); Ishida, T. et al.: Drug Metab. Dispos., 7, 162 (1979);

Formula: C₁₈D₃H₁₈NO₅

Color and Shape: Neat

Molecular weight: 334.382

Ref: TR-O870612

Oxycodone N-oxide

Controlled Product

CAS: 71539-52-1

Oxycodone is an opioid drug that has been used in the treatment of severe pain, cough suppression, and as a preoperative medication. It is available as a single agent or in combination preparations with acetaminophen or ibuprofen. Oxycodone binds to opioid receptors in the central nervous system and increases dopamine levels in the brain. It also inhibits the release of norepinephrine from sympathetic nerve terminals, which may explain its anti-inflammatory effects. Oxycodone can cause dizziness, nausea, vomiting, constipation, and dry mouth when taken at high doses. This drug can interact with other drugs such as nonsteroidal anti-inflammatory drugs (NSAIDs), which will increase the risk for gastrointestinal bleeding and heart attacks. The adverse effects of oxycodone may be reduced by a two-way crossover design study that includes microdialysis probes and multivariate logistic regression analysis.

Formula: C₁₈H₂₁NO₅

Purity: Min. 95%

Molecular weight: 331.4 g/mol

Ref: 3D-WCA53952

Oxycodone Related Compound B CII (oxycodone N-oxide)

Controlled Product

CAS: 71539-52-1

Alkaloids of opium and their derivatives, salts thereof, not elsewhere specified or included

Formula: C₁₈H₂₁NO₅

Color and Shape: Off-White Tan Powder

Molecular weight: 331.14197

Ref: 45-1485227